vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and PEAPACK GLADSTONE FINANCIAL CORP (PGC). Click either name above to swap in a different company.

PEAPACK GLADSTONE FINANCIAL CORP is the larger business by last-quarter revenue ($78.2M vs $45.1M, roughly 1.7× Amarin Corp plc). PEAPACK GLADSTONE FINANCIAL CORP runs the higher net margin — 15.5% vs -23.3%, a 38.8% gap on every dollar of revenue. On growth, PEAPACK GLADSTONE FINANCIAL CORP posted the faster year-over-year revenue change (26.5% vs 7.0%). Over the past eight quarters, PEAPACK GLADSTONE FINANCIAL CORP's revenue compounded faster (21.4% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Peapack Gladstone Financial Corp is a U.S.-based regional financial holding company that provides commercial and consumer banking, wealth management, private banking, lending solutions, and trust services, primarily serving individual and small-to-medium business clients across New Jersey and the surrounding U.S. Northeast region.

AMRN vs PGC — Head-to-Head

Bigger by revenue
PGC
PGC
1.7× larger
PGC
$78.2M
$45.1M
AMRN
Growing faster (revenue YoY)
PGC
PGC
+19.5% gap
PGC
26.5%
7.0%
AMRN
Higher net margin
PGC
PGC
38.8% more per $
PGC
15.5%
-23.3%
AMRN
Faster 2-yr revenue CAGR
PGC
PGC
Annualised
PGC
21.4%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
PGC
PGC
Revenue
$45.1M
$78.2M
Net Profit
$-10.5M
$12.2M
Gross Margin
Operating Margin
35.5%
21.7%
Net Margin
-23.3%
15.5%
Revenue YoY
7.0%
26.5%
Net Profit YoY
33.0%
31.6%
EPS (diluted)
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
PGC
PGC
Q1 26
$45.1M
Q4 25
$49.2M
$78.2M
Q3 25
$49.7M
$70.7M
Q2 25
$72.7M
$69.7M
Q1 25
$42.0M
$64.4M
Q4 24
$62.3M
$61.8M
Q3 24
$42.3M
$56.6M
Q2 24
$67.5M
$56.6M
Net Profit
AMRN
AMRN
PGC
PGC
Q1 26
$-10.5M
Q4 25
$-1.2M
$12.2M
Q3 25
$-7.7M
$9.6M
Q2 25
$-14.1M
$7.9M
Q1 25
$-15.7M
$7.6M
Q4 24
$-48.6M
$9.2M
Q3 24
$-25.1M
$7.6M
Q2 24
$1.5M
$7.5M
Gross Margin
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
PGC
PGC
Q1 26
35.5%
Q4 25
-12.9%
21.7%
Q3 25
-22.4%
19.2%
Q2 25
-22.0%
16.1%
Q1 25
-39.9%
16.2%
Q4 24
-84.3%
19.8%
Q3 24
-59.5%
19.0%
Q2 24
-0.8%
16.9%
Net Margin
AMRN
AMRN
PGC
PGC
Q1 26
-23.3%
Q4 25
-2.5%
15.5%
Q3 25
-15.6%
13.6%
Q2 25
-19.4%
11.4%
Q1 25
-37.4%
11.8%
Q4 24
-78.0%
14.9%
Q3 24
-59.4%
13.4%
Q2 24
2.3%
13.3%
EPS (diluted)
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
$0.00
$0.68
Q3 25
$-0.02
$0.54
Q2 25
$-0.03
$0.45
Q1 25
$-0.04
$0.43
Q4 24
$-0.12
$0.52
Q3 24
$-0.06
$0.43
Q2 24
$0.00
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
PGC
PGC
Cash + ST InvestmentsLiquidity on hand
$307.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$658.2M
Total Assets
$645.8M
$7.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
PGC
PGC
Q1 26
$307.8M
Q4 25
$302.6M
Q3 25
$286.6M
Q2 25
$298.7M
Q1 25
$281.8M
Q4 24
$294.2M
Q3 24
$305.7M
Q2 24
$306.7M
Stockholders' Equity
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
$459.3M
$658.2M
Q3 25
$458.9M
$642.5M
Q2 25
$464.9M
$629.8M
Q1 25
$473.7M
$621.9M
Q4 24
$486.2M
$605.8M
Q3 24
$531.4M
$607.6M
Q2 24
$551.9M
$588.3M
Total Assets
AMRN
AMRN
PGC
PGC
Q1 26
$645.8M
Q4 25
$670.8M
$7.5B
Q3 25
$659.8M
$7.4B
Q2 25
$670.1M
$7.2B
Q1 25
$655.7M
$7.1B
Q4 24
$685.3M
$7.0B
Q3 24
$750.6M
$6.8B
Q2 24
$799.9M
$6.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
PGC
PGC
Operating Cash FlowLast quarter
$43.1M
Free Cash FlowOCF − Capex
$28.8M
FCF MarginFCF / Revenue
36.8%
Capex IntensityCapex / Revenue
18.3%
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters
$61.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
$15.3M
$43.1M
Q3 25
$-12.7M
$36.2M
Q2 25
$16.6M
$15.9M
Q1 25
$-12.5M
$-7.9M
Q4 24
$-13.3M
$71.1M
Q3 24
$-2.4M
$24.7M
Q2 24
$-2.7M
$852.0K
Free Cash Flow
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
$28.8M
Q3 25
$34.0M
Q2 25
$9.9M
Q1 25
$-11.5M
Q4 24
$63.0M
Q3 24
$23.0M
Q2 24
$-431.0K
FCF Margin
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
36.8%
Q3 25
48.1%
Q2 25
14.2%
Q1 25
-17.8%
Q4 24
101.9%
Q3 24
40.6%
Q2 24
-0.8%
Capex Intensity
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
18.3%
Q3 25
3.1%
Q2 25
8.6%
Q1 25
5.6%
Q4 24
13.1%
Q3 24
3.0%
Q2 24
2.3%
Cash Conversion
AMRN
AMRN
PGC
PGC
Q1 26
Q4 25
3.55×
Q3 25
3.76×
Q2 25
2.01×
Q1 25
-1.04×
Q4 24
7.70×
Q3 24
3.25×
Q2 24
-1.81×
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

PGC
PGC

Banking Segment$61.4M79%
Wealth Management Division$13.9M18%
Other$2.9M4%

Related Comparisons